Canagliflozin — Drug Intelligence | 6 EU Trials

Filter these 6 trials by condition, phase, country and more.

6 Registered trials

1 Recruiting

3 Completed trials

6 Sponsors

7 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 5

Indications tested

6 total

CANagliflozin In DIAlysis Patients Pending

2025-522742-46-00 Phase IV 1 country Universitair Medisch Centrum Groningen
Sodium-glucose cotransporter-2 inhibitors to stabilize coronary ather-osclerosis progression after acute myocardial infarction in women and … Pending

2025-523375-29-00 Phase III 1 country Humanitas Mirasole S.p.A.
SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy Recruiting

2025-521748-39-00 Phase IV 1 country Universita Cattolica Del Sacro Cuore
Clinical trial to evaluate whether personalized treatment based on genetics improves type 2 diabetes control Ended

2025-520686-46-00 Phase IV 1 country Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospita…
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Phase IV 4 countries Eli Lilly Cork Limited
GliflOzin in eLderly Diabetic patiENts: A praGmatic intraclass Evaluation trial Ended

2024-518915-20-00 Phase IV 1 country Center For Outcomes Research And Clinical Epidemiology S.r.l.

Showing 1–6 of 6 trials